Tag: COVID-19

COVID-19

DTC Advertising

New Harris Poll Shows Pharma Industry Reputation Is Improving During COVID-19

New Harris Poll Shows Pharma Industry Reputation Is Improving During COVID-19

June 1, 2020 – Although the pharmaceutical industry’s reputation has taken a hit in recent years over drug-pricing concerns, the results of recent Harris Polls show that the industry’s role in helping to combat COVID-19 may be helping to rehabilitate its image. According to Harris Polls conducted between March 14 and May 17, 33 percent […]

Read more

Data Privacy

Hackers Are Targeting COVID-19 Healthcare Data

Hackers Are Targeting COVID-19 Healthcare Data

May 18, 2020 – A joint alert issued recently by the U.S. Cybersecurity and Infrastructure Security Agency (CISA) and the U.K. National Cyber Security Centre (NCSC) warns that they continue to see “indications that advanced persistent threat (APT) groups are exploiting the [COVID-19] pandemic” by targeting organizations involved in the COVID-19 response, including “healthcare bodies, […]

Read more

Regulatory/FDA

As COVID-19 Pandemic Continues, Promotion of Unapproved “Cures” Abounds

As COVID-19 Pandemic Continues, Promotion of Unapproved “Cures” Abounds

May 4, 2020 – An important part of protecting the public health during the COVID-19 pandemic is making sure that the marketing of treatments or remedies that are not approved by the Food and Drug Administration (FDA) to treat the virus is stopped before consumers waste their money or potentially are harmed by these products. […]

Read more

Regulatory/FDA

COVID-19 Pandemic Likely to Affect FDA Product Approval Timelines

COVID-19 Pandemic Likely to Affect FDA Product Approval Timelines

April 27, 2020 – As the COVID-19 pandemic continues, the Food and Drug Administration (FDA) must balance safeguarding public health with the desire for timely product reviews. Staff members at the Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research are working diligently to keep all of these balls in […]

Read more

Regulatory/FDA

FDA Streamlines COVID-19 Product Pathways, Continues to Crack Down on Misleading Claims

FDA Streamlines COVID-19 Product Pathways, Continues to Crack Down on Misleading Claims

April 13, 2020 – The Food and Drug Administration (FDA) is responding to the challenges of COVID-19 in new ways that streamline product review and policy approaches, while also ensuring that entities promoting unapproved products that claim to be effective against the virus do not go unchecked. Last week, the FDA and the Federal Trade […]

Read more

Legislative

Emergency Relief Package Yields Increased FDA Funding, OTC Revisions

Emergency Relief Package Yields Increased FDA Funding, OTC Revisions

March 30, 2020 – In addition to providing millions of Americans and many industries with financial support during the coronavirus outbreak, the emergency relief bill passed by Congress and signed into law by President Donald Trump on Friday accrues additional funding for the Food and Drug Administration’s coronavirus efforts and makes important changes to how […]

Read more

General

Amid COVID-19 Outbreak, Protecting 2020 Election Should Start Now

Amid COVID-19 Outbreak, Protecting 2020 Election Should Start Now

March 23, 2020 – As the United States grapples with the COVID-19 outbreak and its ongoing fallout, there is another pressing issue that is crucial to the American public: ensuring safe and fair elections between now and Nov. 3. “The Coalition believes it is important for all Americans to be active in the political process […]

Read more

Regulatory/FDA

FDA and FTC: Coronavirus Products Are Fraudulent, Could Delay Treatment

FDA and FTC: Coronavirus Products Are Fraudulent, Could Delay Treatment

March 16, 2020 – Amid rising concerns over “Novel Coronavirus Disease 2019” (COVID-19), the Food and Drug Administration and the Federal Trade Commission took action last week against seven companies for selling fraudulent COVID-19 products. The regulators sent Warning Letters to the companies because these products “are unapproved drugs that pose significant risks to patient […]

Read more